Literature DB >> 1374315

Interferons 1992. How much of the promise has been realised?

M A Volz1, C H Kirkpatrick.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1374315     DOI： 10.2165/00003495-199243030-00001

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  111 in total

Review 1.  Interferon therapy in cancer: from imaginon to interferon.

Authors:  D Goldstein; J Laszlo
Journal:  Cancer Res       Date:  1986-09       Impact factor: 12.701

2.  Recombinant gamma interferon in treatment of patients with atopic dermatitis and elevated IgE levels.

Authors:  M Boguniewicz; H S Jaffe; A Izu; M J Sullivan; D York; R S Geha; D Y Leung
Journal:  Am J Med       Date:  1990-04       Impact factor: 4.965

3.  IL-4 inhibits the synthesis of IFN-gamma and induces the synthesis of IgE in human mixed lymphocyte cultures.

Authors:  D Vercelli; H H Jabara; R P Lauener; R S Geha
Journal:  J Immunol       Date:  1990-01-15       Impact factor: 5.422

4.  Alpha-interferon for severe cold agglutinin disease.

Authors:  B M O'Connor; J S Clifford; W D Lawrence; G L Logue
Journal:  Ann Intern Med       Date:  1989-08-01       Impact factor: 25.391

5.  Preliminary observations on the effect of human leukocyte interferon in non-Hodgkin's lymphoma.

Authors:  T C Merigan; K Sikora; J H Breeden; R Levy; S A Rosenberg
Journal:  N Engl J Med       Date:  1978-12-28       Impact factor: 91.245

6.  The effect of an intralesional sustained-release formulation of interferon alfa-2b on basal cell carcinomas.

Authors:  L Edwards; S B Tucker; D Perednia; K A Smiles; E L Taylor; D J Tanner; E Peets
Journal:  Arch Dermatol       Date:  1990-08

7.  Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy.

Authors:  F Mandelli; G Avvisati; S Amadori; M Boccadoro; A Gernone; V M Lauta; F Marmont; M T Petrucci; M Tribalto; M L Vegna
Journal:  N Engl J Med       Date:  1990-05-17       Impact factor: 91.245

8.  Activation of tissue macrophages from AIDS patients: in vitro response of AIDS alveolar macrophages to lymphokines and interferon-gamma.

Authors:  H W Murray; R A Gellene; D M Libby; C D Rothermel; B Y Rubin
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

9.  Effects of interferon-alpha on cytomegalovirus reactivation syndromes in renal-transplant recipients.

Authors:  M S Hirsch; R T Schooley; A B Cosimi; P S Russell; F L Delmonico; N E Tolkoff-Rubin; J T Herrin; K Cantell; M L Farrell; T R Rota; R H Rubin
Journal:  N Engl J Med       Date:  1983-06-23       Impact factor: 91.245

10.  Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria.

Authors:  G S Douvas; D L Looker; A E Vatter; A J Crowle
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441
View more
  2 in total

Review 1.  Interferons in multiple sclerosis. A review of the evidence.

Authors:  H S Panitch
Journal:  Drugs       Date:  1992-12       Impact factor: 9.546

Review 2.  Clinical toxicity of the interferons.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1994-02       Impact factor: 5.606
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.